Pipeline

Our Research

Gynecological Oncology

Platinum-resistant ovarian cancer (PROC)
CBP-1008 , CBP-1019

Genitourinary Oncology

Metastatic castration-resistant prostate cancer (mCRPC)
CBP-1018 , CBP-8088

Gastrointestinal Cancer

Pancreatic cancer
CBP-1019
Esophagus cancer
CBP-1019

Thoracic Malignancies

Triple-negative breast cancer (TNBC)
CBP-1008 , CBP-8088
Lung cancer (LC)
CBP-1019 , CBP-8088

Bone Metastases

CBP-1018
CBP-1203

Pipeline

 

Product

Indications

Target

Payload

Pre-clinical

IND enabling

Phase I

Phase II/III

NDA

 

CBP-1008

 

 PROC
TNBC

 

FRα × TRPV6

 

 Tubulin
Inhibitor

 

CBP-1018

 

mCRPC
Bone metastases

FRα × PSMA

 

Tubulin
Inhibitor

 

CBP-1019

PROC
LC
Pancreatic cancer
Esophagus cancer

 

FRα × TRPV6

Topoisomerase Inhibitor

CBP-1029

Solid cancer

 

undisclosed

 

Topoisomerase Inhibitor

CBP-8088

 

mCRPC
TNBC

 

undisclosed

PROTAC

CBP-1039

Solid cancer

undisclosed

Topoisomerase Inhibitor

CBP-1203

Solid cancer

undisclosed

 

Radioactive Isotope

CBP-1602

Solid cancer

undisclosed

 

Photodynamic Therapies